TY - JOUR
T1 - EULAR recommendations for the management of primary small and medium vessel vasculitis
AU - Mukhtyar, C.
AU - Guillevin, L.
AU - Cid, M. C.
AU - Dasgupta, B.
AU - De Groot, K.
AU - Gross, W.
AU - Hauser, T.
AU - Hellmich, B.
AU - Jayne, D.
AU - Kallenberg, C. G.M.
AU - Merkel, P. A.
AU - Raspe, H.
AU - Salvarani, C.
AU - Scott, D. G.I.
AU - Stegeman, C.
AU - Watts, R.
AU - Westman, K.
AU - Witter, J.
AU - Yazici, H.
AU - Luqmani, R.
N1 - Copyright:
Copyright 2009 Elsevier B.V., All rights reserved.
PY - 2009/3
Y1 - 2009/3
N2 - Objectivas: To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis. Methods: An expert group (consisting of 10 rheumatologists, 3 nephrologists, 2 immunologists, 2 internists representing 8 European countries and the USA, a clinical epidemiologist and a representative from a drug regulatory agency) identified 10 topics for a systematic literature search using a modified Delphi technique. In accordance with standardised EULAR operating procedures, recommendations were derived for the management of small and medium vessel vasculitis. In the absence of evidence, recommendations were formulated on the basis of a consensus opinion. Results: In all, 15 recommendations were made for the management of small and medium vessel vasculitis. The strength of recommendations was restricted by low quality of evidence and by EULAR standardised operating procedures. Conclusions: On the basis of evidence and expert consensus, recommendations have been made for the evaluation, investigation, treatment and monitoring of patients with small and medium vessel vasculitis for use in everyday clinical practice.
AB - Objectivas: To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis. Methods: An expert group (consisting of 10 rheumatologists, 3 nephrologists, 2 immunologists, 2 internists representing 8 European countries and the USA, a clinical epidemiologist and a representative from a drug regulatory agency) identified 10 topics for a systematic literature search using a modified Delphi technique. In accordance with standardised EULAR operating procedures, recommendations were derived for the management of small and medium vessel vasculitis. In the absence of evidence, recommendations were formulated on the basis of a consensus opinion. Results: In all, 15 recommendations were made for the management of small and medium vessel vasculitis. The strength of recommendations was restricted by low quality of evidence and by EULAR standardised operating procedures. Conclusions: On the basis of evidence and expert consensus, recommendations have been made for the evaluation, investigation, treatment and monitoring of patients with small and medium vessel vasculitis for use in everyday clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=61449238213&partnerID=8YFLogxK
U2 - 10.1136/ard.2008.088096
DO - 10.1136/ard.2008.088096
M3 - Journal articles
C2 - 18413444
AN - SCOPUS:61449238213
SN - 0003-4967
VL - 68
SP - 310
EP - 317
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 3
ER -
